Author(s):
R. Sarah Sathiyawathie, Dhanraj Ganapathy
Email(s):
dr.sarahrobin@gmail.com
DOI:
10.5958/0974-360X.2018.00594.2 
Address:
R. Sarah Sathiyawathie1, Dhanraj Ganapathy2
1Tutor Department, of Conservative and Endodontics, Saveetha Dental College, Saveetha University, Chennai, India.
2Professor and Head of Department, Department of Prosthodontics, Saveetha Dental College, Saveetha University, Chennai, India.
*Corresponding Author
Published In:
Volume - 11,
Issue - 7,
Year - 2018
ABSTRACT:
Osteoradionecrosis has been a serious and not infrequent complication that can affect both adults and children following radiation therapy. The incidence of osteoradionecrosis varies widely in the literature ranging from 1% to 37%. Over the last few decades, several therapeutic options including supportive measures, ultrasound therapy, corticosteroids, hyperbaric oxygen, surgical resection with reconstruction and most recently drugs capable of reversing the fibroatrophic process were considered in the treatment of osteroradionecrosis of the mandible.
Cite this article:
R. Sarah Sathiyawathie, Dhanraj Ganapathy. Management of Osteoradionecrosis of the Mandible. Research J. Pharm. and Tech 2018; 11(7): 3234-3236. doi: 10.5958/0974-360X.2018.00594.2
Cite(Electronic):
R. Sarah Sathiyawathie, Dhanraj Ganapathy. Management of Osteoradionecrosis of the Mandible. Research J. Pharm. and Tech 2018; 11(7): 3234-3236. doi: 10.5958/0974-360X.2018.00594.2 Available on: https://rjptonline.org/AbstractView.aspx?PID=2018-11-7-93